Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Minority Interest (2021 - 2025)

PAVmed has reported Minority Interest over the past 5 years, most recently at -$11.7 million for Q4 2025.

  • Quarterly results put Minority Interest at -$11.7 million for Q4 2025, down 157.1% from a year ago — trailing twelve months through Dec 2025 was -$11.7 million (down 157.1% YoY), and the annual figure for FY2025 was -$11.7 million, down 157.1%.
  • Minority Interest for Q4 2025 was -$11.7 million at PAVmed, down from -$10.0 million in the prior quarter.
  • Over the last five years, Minority Interest for PAVM hit a ceiling of $56.3 million in Q3 2024 and a floor of -$11.7 million in Q4 2025.
  • Median Minority Interest over the past 5 years was $19.1 million (2022), compared with a mean of $16.6 million.
  • Biggest five-year swings in Minority Interest: skyrocketed 5286.81% in 2022 and later tumbled 157.1% in 2025.
  • PAVmed's Minority Interest stood at $17.8 million in 2021, then grew by 16.13% to $20.6 million in 2022, then skyrocketed by 44.62% to $29.8 million in 2023, then tumbled by 115.22% to -$4.5 million in 2024, then tumbled by 157.1% to -$11.7 million in 2025.
  • The last three reported values for Minority Interest were -$11.7 million (Q4 2025), -$10.0 million (Q3 2025), and -$9.4 million (Q2 2025) per Business Quant data.